Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine in OCD
NCT05577585Recruiting
- Sponsor
- Medical University of Vienna
- Start
- Oct 2022
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ketamine in obsessive compulsive disorder (OCD) (3 arms), sponsored by Medical University of Vienna. Primary endpoint: Yale-Brown Obsessive Compulsive Scale. Started Oct 2022; status: recruiting.
02
Drugs
ketamine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT05577585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05577585.